New quinolone resistance phenomenon in Salmonella enterica:: Nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility

被引：35

作者：

Hakanen, AJ

Lindgren, M

Huovinen, P

Jalava, J

Siitonen, A

Kotilainen, P

机构：

[1] Natl Publ Hlth Inst, Antimicrobial Res Lab, Turku 20521, Finland

[2] Natl Publ Hlth Inst, Lab Human Microbial Ecol, Turku 20521, Finland

[3] Natl Publ Hlth Inst, Enter Bacteria Lab, Turku 20521, Finland

[4] Natl Publ Hlth Inst, Dept Bacterial & Inflammatory Dis, Turku 20521, Finland

[5] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2005年 / 43卷 / 11期

关键词：

D O I：

10.1128/JCM.43.11.5775-5778.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We describe the emergence of a new quinolone resistance pattern in Salmonella enterica isolates from Southeast Asia. These isolates are susceptible to nalidixic acid but exhibit reduced susceptibility to ciprofloxacin. The increase of such strains may threaten the value of the nalidixic acid disk test to screen for reduced fluoroquinolone susceptibility in salmonellas.

引用

页码：5775 / 5778

页数：4

共 21 条

[1]

[Anonymous], 2003, M2A8 NAT COMM CLIN L

[2]

[Anonymous], 2004, M100S14 NAT COMM CLI

[3]

[Anonymous], [No title captured]

[4] Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs [J].